Literature DB >> 8880534

Ribosomal DNA typing of Haemophilus ducreyi strains: proposal for a novel typing scheme.

A Pillay1, A A Hoosen, P Kiepiela, A W Sturm.   

Abstract

Local strains of Haemophilus ducreyi were characterized by ribosomal DNA fingerprinting in order to develop a typing scheme for this organism. Chromosomal DNAs from 30 strains were extracted, and restriction fragments were separated by agarose gel electrophoresis after cleavage with BglII, HindIII, HindII, and BstEII. Of the 30 local strains studied, nine BglII, eight HindIII, six HindII, and five BstEII ribotype patterns were observed. In order to develop a typing scheme, we correlated the ribotype patterns obtained with each of the four enzymes for each strain. By this scheme, 13 ribotypes designated b to n were defined among the local strains. This study demonstrates that there is a diversity of ribotypes among H. ducreyi strains in our area, which emphasizes that there are many strains responsible for chancroid. This novel typing scheme provides a useful tool for further epidemiological studies of chancroid.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8880534      PMCID: PMC229334          DOI: 10.1128/jcm.34.10.2613-2615.1996

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  12 in total

1.  Enzyme profile of Haemophilus ducreyi strains isolated on different continents.

Authors:  E Van Dyck; P Piot
Journal:  Eur J Clin Microbiol       Date:  1987-02       Impact factor: 3.267

2.  Molecular characterization of Haemophilus ducreyi by ribosomal DNA fingerprinting.

Authors:  S K Sarafian; T C Woods; J S Knapp; B Swaminathan; S A Morse
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

3.  A broad-spectrum probe for molecular epidemiology of bacteria: ribosomal RNA.

Authors:  T L Stull; J J LiPuma; T D Edlind
Journal:  J Infect Dis       Date:  1988-02       Impact factor: 5.226

4.  Lectin typing of Haemophilus ducreyi.

Authors:  H C Korting; D Abeck; A P Johnson; R C Ballard; D Taylor-Robinson; O Braun-Falco
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-10       Impact factor: 3.267

5.  Non-radioactive ribotyping of Haemophilus ducreyi using a digoxigenin labelled cDNA probe.

Authors:  T J Brown; C A Ison
Journal:  Epidemiol Infect       Date:  1993-04       Impact factor: 2.451

6.  Characteristics of Haemophilus ducreyi in culture.

Authors:  A W Sturm; H C Zanen
Journal:  J Clin Microbiol       Date:  1984-05       Impact factor: 5.948

7.  The development of specific rRNA-derived oligonucleotide probes for Haemophilus ducreyi, the causative agent of chancroid.

Authors:  R Rossau; M Duhamel; G Jannes; J L Decourt; H Van Heuverswyn
Journal:  J Gen Microbiol       Date:  1991-02

8.  Characterization of cell proteins of Haemophilus ducreyi by polyacrylamide gel electrophoresis.

Authors:  J A Odumeru; A R Ronald; W L Albritton
Journal:  J Infect Dis       Date:  1983-10       Impact factor: 5.226

9.  Antimicrobial susceptibility and characterization of outer membrane proteins of Haemophilus ducreyi isolated in Thailand.

Authors:  D N Taylor; P Echeverria; S Hanchalay; C Pitarangsi; L Slootmans; P Piot
Journal:  J Clin Microbiol       Date:  1985-03       Impact factor: 5.948

10.  Sexually transmitted diseases and human immunodeficiency virus control in Malawi: a field study of genital ulcer disease.

Authors:  F M Behets; G Liomba; G Lule; G Dallabetta; I F Hoffman; H A Hamilton; S Moeng; M S Cohen
Journal:  J Infect Dis       Date:  1995-02       Impact factor: 5.226

View more
  2 in total

1.  The Use of Molecular Techniques for the Diagnosis and Epidemiologic Study of Sexually Transmitted Infections.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-02       Impact factor: 3.725

2.  Molecular characterization of Haemophilus ducreyi isolates from different geographical locations.

Authors:  J Mbwana; I Bölin; E Lyamuya; F Mhalu; T Lagergård
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.